Heart and Vascular Centre, Segeberger Kliniken GmbH, Bad Segeberg, Germany.
EuroIntervention. 2011 May;7(1):57-63. doi: 10.4244/EIJV7I8A12.
Echocardiography may underestimate the degree of paravalvular aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) using the Medtronic CoreValve bioprosthesis due to inherent limitations of ultrasound imaging in the evaluation of implanted cardiac prostheses. We aimed to evaluate the accuracy and feasibility of cardiovascular magnetic resonance (CMR) in quantifying regurgitant volume (RV) and regurgitant fraction (RF) in patients treated with this bioprosthesis for severe calcific aortic stenosis, and to compare the results with echocardiography and aortography.
This study included 16 patients with a mean age of 78.7 years (eight women, eight men) who underwent successful TAVI using Medtronic CoreValve bioprosthesis. AR was evaluated by CMR, echocardiography, and aortography. Angiography was performed immediately after valve implantation. CMR and echocardiography were performed four weeks after valve implantation. There was a highly significant correlation between the CMR-derived and the angiographically-estimated degree of AR (r=0.86, p<0.001). On the other hand, there was only a limited correlation between CMR and echocardiography (r=0.374, p=0.15) as well as angiography and echocardiography (r=0.319, p=0.23) regarding the degree of AR. The weighted kappa for agreement between echocardiography and angiography was 0.14, for agreement between echocardiography and CMR 0.20, and for agreement between angiography and CMR 0.72. Echocardiography underestimated AR by one degree compared to CMR in five patients and 2 degrees in two patients; in six of these, the degree of AR obtained by CMR was similar to angiography.
In patients undergoing TAVI, comparisons between purely quantitative measurements of AR by CMR and qualitative assessment by angiography showed better correlations than those with echocardiography. This suggests that echocardiography may underestimate the degree of AR and CMR in these circumstances has a great potential in reliably measuring the severity of AR in a quantitative manner.
经导管主动脉瓣置换术(TAVI)使用美敦力 CoreValve 生物瓣后,由于超声成像在评估植入式心脏瓣膜方面存在固有局限性,可能会低估瓣周主动脉反流(PAR)的程度。我们旨在评估心血管磁共振(CMR)在量化严重钙化性主动脉瓣狭窄患者接受该生物瓣治疗后的反流量(RV)和反流分数(RF)的准确性和可行性,并将结果与超声心动图和主动脉造影进行比较。
这项研究纳入了 16 名平均年龄为 78.7 岁(8 名女性,8 名男性)的患者,他们均成功接受了美敦力 CoreValve 生物瓣的 TAVI。通过 CMR、超声心动图和主动脉造影评估 AR。在瓣膜植入后立即进行血管造影。在瓣膜植入后 4 周进行 CMR 和超声心动图检查。CMR 测量的 PAR 程度与血管造影估计的程度之间具有高度显著相关性(r=0.86,p<0.001)。另一方面,CMR 与超声心动图(r=0.374,p=0.15)以及血管造影与超声心动图(r=0.319,p=0.23)之间的 PAR 程度仅有有限的相关性。超声心动图与血管造影之间的一致性加权 kappa 为 0.14,超声心动图与 CMR 之间的一致性加权 kappa 为 0.20,血管造影与 CMR 之间的一致性加权 kappa 为 0.72。在 5 名患者中,超声心动图比 CMR 低估了一个 PAR 程度,在 2 名患者中低估了两个 PAR 程度;在这 6 名患者中,CMR 测量的 PAR 程度与血管造影相似。
在接受 TAVI 的患者中,CMR 对 PAR 的纯定量测量与血管造影的定性评估之间的比较显示出比与超声心动图之间更好的相关性。这表明,在这种情况下,超声心动图可能会低估 PAR 的程度,而 CMR 具有可靠地以定量方式测量 PAR 严重程度的巨大潜力。